Investing in stocks – May #stocks, #how #to #invest #in #stocks, #what #is #a #stock, #how #do #i #buy #stocks, #buying #stocks, #investing #in #stocks, #choosing #stocks, #stock, #stock #picking, #large #cap, #small #cap, #mid #cap, #value, #growth, #cyclical, #sector, #industry, #value #stock, #growth #stock, #dow #jones #stocks, #stocks #to #buy, #dividend #stocks, #how #to #value #stock

Posted On Sep 12 2017 by

# Investing in stocks Since the end of World War II the average large stock has returned close to 10% a year — well ahead of inflation, and the return of bonds, real estate and other savings vehicles. As a result, stocks are the best way to save money for long-term goals. When you own a share of stock, you are a part owner in the company with a claim — however small it may be — on every asset and every penny in earnings. As a company’s earnings improve, investors are willing to pay more for the stock. How …


SteriPack Drives Pharmaceutical Packaging Growth – Blister Packaging #pharmaceutical #sales #jobs

Posted On Sep 8 2017 by

#pharmaceutical packaging companies # PL + 48 71381 8199 MY + 60 33167 3596 US + 1 863 648 2333 SteriPack Malaysia Drives Pharmaceutical Packaging Growth SteriPack s facility in Malaysia ensures that the group can offer state of the art blister packaging services all over the globe. SteriPack is a worldwide packaging solutions provider, serving the medical device and pharmaceutical industries. Since its foundation in 1994, the company has invested significantly by building its processes and quality systems to extremely high standards throughout its facilities located in Ireland, Poland, Malaysia, and the US. In recent times, SteriPack s facility …


SteriPack Drives Pharmaceutical Packaging Growth – Blister Packaging #hetero #pharma

Posted On Aug 28 2017 by

#pharmaceutical packaging companies # PL + 48 71381 8199 MY + 60 33167 3596 US + 1 863 648 2333 SteriPack Malaysia Drives Pharmaceutical Packaging Growth SteriPack s facility in Malaysia ensures that the group can offer state of the art blister packaging services all over the globe. SteriPack is a worldwide packaging solutions provider, serving the medical device and pharmaceutical industries. Since its foundation in 1994, the company has invested significantly by building its processes and quality systems to extremely high standards throughout its facilities located in Ireland, Poland, Malaysia, and the US. In recent times, SteriPack s facility …


Global needs drive growth of pharmaceutical industry – Market Realist #schwarz #pharma

Posted On Aug 26 2017 by

#pharmaceutical industry growth # Global needs drive growth of pharmaceutical industry Aging population Worldwide, the average human life span has increased substantially over the last few decades. However, more infections and diseases have come along with this longevity growth. This has led to increased research on aging populations. The goals are to prevent infections and maintain health so that these populations can enjoy better lives. Changing lifestyles Hectic daily schedules have led to unhealthy eating habits, a lack of exercise, less sleep, and other problematic lifestyle choices. This has resulted in high obesity rates, poor digestion, hallucinations, breathing difficulties, and …


Pharmaceutical Industry Analysis: Market Research, Survey, Growth & Reports #biotechnology

Posted On Aug 20 2017 by

#pharmaceutical industry analysis # Pharmaceutical Industry Analysis: Market Research, Survey, Growth & Reports Indian Pharma Sector India is among the top six global pharmaceutical producers in the world. Indian vaccines are exported to 150 countries. India produces 40-70 per cent of the WHO demand for DPT & BCG and 90 per cent of measles vaccine. Approximately 70 per cent of the patients in developing countries receive Indian medicines through NGOs like The Clinton Foundation, Bill & Melinda Gates Foundation, Doctors Without Borders, the UNCTAD etc. Presently there are 10,500 manufacturing units and over 3,000 pharma companies in India, growing at …


SteriPack Drives Pharmaceutical Packaging Growth – Blister Packaging #pharma #pro

Posted On Aug 16 2017 by

#pharmaceutical packaging companies # PL + 48 71381 8199 MY + 60 33167 3596 US + 1 863 648 2333 SteriPack Malaysia Drives Pharmaceutical Packaging Growth SteriPack s facility in Malaysia ensures that the group can offer state of the art blister packaging services all over the globe. SteriPack is a worldwide packaging solutions provider, serving the medical device and pharmaceutical industries. Since its foundation in 1994, the company has invested significantly by building its processes and quality systems to extremely high standards throughout its facilities located in Ireland, Poland, Malaysia, and the US. In recent times, SteriPack s facility …


Strong Growth Ahead for Contract Manufacturing #novartis #pharma

Posted On Aug 12 2017 by

#pharmaceutical contract manufacturer # Pharma Manufacturing Strong Growth Ahead for Contract Manufacturing Contract manufacturing organizations (CMOs) of small- and large-molecule drug substances and formulated drug products have had profitable businesses in recent years, including 2015. Growth rates for contract manufacturing have been much higher than that of the market for the pharmaceutical/biopharmaceutical industry due to several factors: • Increasing consumption of medicines around the world, both in emerging markets as incomes rise and mature markets due to aging of the population; • A more robust pipeline of drug candidates and an increasing rate of FDA NDA/BLA approvals; • The growing …


Pharma major Lupin targets $1 bn revenue from inorganic growth by FY18 #generic #pharmaceuticals

Posted On Aug 8 2017 by

#lupin pharma # Pharma major Lupin targets $1 bn revenue from inorganic growth by FY18 Sohini Das | Ahmedabad Jan 19, 2016 10:01 AM IST Looking to add $1 billion in revenues from inorganic growth to reach its target turnover of $5 billion by 2018, pharma giant Lupin, which is currently worth $2 billion, says it is open to late stage speciality assets. Lupin s chief financial officer Ramesh Swaminathan told Business Standard that while $200-300 million per acquisition is a sweet spot for the company historically, it does not mean that the company won t look at bigger acquisitions. …


Strong Growth Ahead for Contract Manufacturing #bio #pharma

Posted On Jul 28 2017 by

#pharmaceutical contract manufacturer # Pharma Manufacturing Strong Growth Ahead for Contract Manufacturing Contract manufacturing organizations (CMOs) of small- and large-molecule drug substances and formulated drug products have had profitable businesses in recent years, including 2015. Growth rates for contract manufacturing have been much higher than that of the market for the pharmaceutical/biopharmaceutical industry due to several factors: • Increasing consumption of medicines around the world, both in emerging markets as incomes rise and mature markets due to aging of the population; • A more robust pipeline of drug candidates and an increasing rate of FDA NDA/BLA approvals; • The growing …


Pharmaceutical Industry Trends, Analysis, Statistics – Market Growth #pharma #iq

Posted On Jul 23 2017 by

#pharmaceutical industry growth # Pharmaceutical Industry Analysis: Latest Market Research Reports Topics under Pharmaceutical Global Pharmaceutical Industry Overview The pharmaceutical industry consists of companies involved in the research, development and marketing of drugs and biologics. The pharmaceutical market was valued at $1 trillion in 2013, according to IMS. The market grew at a 4% compound annual growth rate (CAGR) from 2009 to 2013. It grew well in 2010 and 2011 before a decline in growth in 2012 and 2013. The pharmaceutical market was driven by a rise in healthcare spending and high growth in both emerging markets and the biologics …